Skip to search formSkip to main contentSkip to account menu

Diazoxide

Known as: Diazoxide [Chemical/Ingredient], 3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-Dioxide, 2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide 
A benzothiadiazine derivate with antihypertensive and hyperglycemic activities. Diazoxide increases membrane permeability to potassium ions in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1977
Highly Cited
1977
Persistent hypoglycemia in the neonate and young infant usually results from inappropriate, excessive secretion of insulin, or a… 
1977
1977
Diazoxide was administered to sixteen pediatric patients (ages 10 months to 13 years) with secondary forms of hypertension… 
Review
1976
Review
1976
Current knowledge of the mechanism of inflammatory mediator release from mast cells is reviewed with particular reference to the… 
1971
1971
Hyperglycemic hyperosmolar nonketoacidotic coma developed in a twenty-year-old female with uremia when treated for hypertension… 
1971
1971
Glucose produced a diphasic pattern of insulin secretion in the perfused rat pancreas. Both phases were blocked by diazoxide… 
1971
1971
Diazoxide inhibits spontaneous motility and contractile responses to noradrenaline, serotonin, or procaine in isolated rabbit… 
1971
1971
This communication reports studies dealing with the action of glucagon, theophylline, cyclic adenosine monophosphate (3′5′.AMP… 
1970
1970
Continuous glucose stimulation produces two phases of insulin secretion in the isolated perfused rat pancreas. Puromycin has no… 
Highly Cited
1969
Highly Cited
1969
1. Degranulation of B-ceUs of rats infused with guinea-pig anti-insulin serum (AIS) for 3-4 hrs ean be prevented completely by… 
1967
1967
Abstract The mechanism of action of diazoxide vas investigated in dogs. Immunoreactive insulin, glucose, and free fatty acids…